South Africa may sell AstraZeneca shots as it switches to J&J vaccine to fight variant | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
June 09, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, JUNE 09, 2025
South Africa may sell AstraZeneca shots as it switches to J&J vaccine to fight variant

Coronavirus chronicle

Reuters
11 February, 2021, 10:35 am
Last modified: 11 February, 2021, 10:38 am

Related News

  • South Africa town leader 'sad' about Trump's misuse of white crosses video
  • Trump confronts South Africa's Ramaphosa with false claims of white genocide
  • First white South Africans arrive in US as Trump claims they face discrimination
  • First white South Africans board plane for US under Trump refugee plan
  • First white South Africans to arrive under US refugee plan as soon as next week

South Africa may sell AstraZeneca shots as it switches to J&J vaccine to fight variant

One million doses of the AstraZeneca vaccine, produced by the Serum Institute of India, landed in the country last week, and another 500,000 are due to arrive in coming weeks

Reuters
11 February, 2021, 10:35 am
Last modified: 11 February, 2021, 10:38 am
A woman walks past newspaper billboards during the coronavirus disease (COVID-19) outbreak in Johannesburg, South Africa, February 8, 2021. REUTERS/Sumaya Hisham/File Photo
A woman walks past newspaper billboards during the coronavirus disease (COVID-19) outbreak in Johannesburg, South Africa, February 8, 2021. REUTERS/Sumaya Hisham/File Photo

South Africa's health minister said on Wednesday the government may sell doses of AstraZeneca's Covid-19 vaccine it may not need or swap for a different vaccine, as it scrambles to start inoculating its citizens with an alternative US shot next week.

The unusual move comes just days after South Africa paused the rollout of the vaccine developed by AstraZeneca and Oxford University following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 variant dominant in the country.

One million doses of the AstraZeneca vaccine, produced by the Serum Institute of India, landed in the country last week, and another 500,000 are due to arrive in coming weeks. That's enough to inoculate 750,000 people.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

South Africa was also expecting to receive AstraZeneca shots via the Covax global vaccine distribution scheme co-led by the World Health Organization (WHO) and an African Union (AU) arrangement.

Health Minister Zweli Mkhize told a news conference the country would start vaccinating health workers with Johnson & Johnson's vaccine in the form of an "implementation study" with researchers sometime next week.

He said he would wait for advice from scientists before proceeding with the possible sale or switch of the British shot.

"Why not sell the AstraZeneca to other countries? Well it's an option ... we will consider it. First our scientists will tell us what we do with it. Can we use it within the time that's available ... before it expires?" Mkhize said.

"If not, can we swap it with anyone else, because we've discussed it with Covax and with AVATT (the AU's vaccine task team), so we will see what we will do."

It is not clear how a sale or swap would work given the varying prices for vaccines around the world, or whether the British drugmaker would have to agree to such a move. The Serum Institute and AstraZeneca declined to comment.

Still, in a briefing to lawmakers later in the day, Mkhize said the government wanted to see whether it could swap AstraZeneca shots it had ordered from the Serum Institute for doses of a different vaccine available under the Covax scheme run by the WHO and international vaccines alliance Gavi.

The move is the latest twist in a saga that has engulfed South Africa this week as it tries to tame the fast-spreading variant. The country's death toll is nearing 47,000 and infections have surpassed 1.47 million.

A WHO panel said on Wednesday that the AstraZeneca vaccine was safe and effective and should be deployed widely, including in countries where the 501Y.V2 variant could reduce its efficacy. Gavi said Covax was exploring ways for countries participating in the facility to exchange vaccine doses with each other to optimise for their needs.

Alternatives

Turning to J&J for alternative supplies is another blow to AstraZeneca, whose vaccine is considered critical for poor nations because it is cheap and easy to store.

South Africa's Ministerial Advisory Committee should be able to give a considered view on how to deal with the AstraZeneca vaccine in the next week or two, Mkhize said, adding the government had also secured doses from Pfizer for health workers.

Negotiations with Moderna, China's Sinopharm and over Russia's Sputnik V vaccine are ongoing.

Mkhize referred to the first batch of J&J doses as "bridging stock" and said they could arrive next week.

Officials previously said the country had secured 9 million J&J single-dose shots, and Mkhize said a deal could be finalised soon.

Glenda Gray, Medical Research Council (MRC) president, said the government and the MRC aimed to immunise up to 500,000 health workers in the J&J study, with batches of around 80,000 doses arriving every seven to 14 days once the study is approved.

Eventually, most of the J&J supplies could come from local pharmaceutical company Aspen, which is due to bring production on stream around April, Mkhize said.

The J&J vaccine was 89% effective at preventing severe disease and 57% effective against moderate to severe disease in the South African leg of a large global trial. About 95% of infections in the local study were due to the 501Y.V2 variant.

The variant has alarmed health experts who have raised concerns about its ability to potentially evade the immune response generated by prior exposure to the coronavirus or vaccines.

South Africa's neighbour eSwatini said on Tuesday it would not use the AstraZeneca vaccine.

Top News / World+Biz

AstraZeneca Covid-19 Vaccine / AstraZeneca vaccine / AstraZeneca's vaccine / Oxford-AstraZeneca / Oxford-AstraZeneca vaccine / south africa / South African Covid strain

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Chief Adviser Muhammad Yunus leaves for a four-day visit to the United Kingdom from the Dhaka airport on 9 June 2025. Photo: CA Press Wing
    CA Yunus leaves for UK; discussion expected on renewable energy investment, laundered money
  • California Governor Gavin Newsom. File Photo: REUTERS/Fred Greaves
    California Governor Newsom to sue Trump over National Guard deployment amid LA protests
  • File photo of Shafiqul Alam. Photo: Collected
    Positive message for country if CA meets Tarique, but no decision on meeting yet: Shafiqul tells Somoy

MOST VIEWED

  • On left, Abdullah Hil Rakib, former senior vice president (SVP) of BGMEA and additional managing director of Team Group; on right, Captain Md Saifuzzaman (Guddu), a Boeing 787 Dreamliner pilot for Biman Bangladesh Airlines. Photos: Collected
    Ex-BGMEA SVP Abdullah Hil Rakib, Biman 787 pilot Saifuzzaman drown in boating accident in Canada
  • A photo showing the former president on his return to Dhaka today (9 June). 
Source: Collected
    Former president Abdul Hamid returns to Bangladesh from Thailand
  • File Photo: British MP Tulip Siddiq attends a news conference with Richard Ratcliffe, the husband of jailed British-Iranian aid worker Nazanin Zaghari-Ratcliffe, in London, Britain October 11, 2019. Photo: REUTERS/Peter Nicholls/File Photo
    Tulip requests CA Yunus for a meeting over corruption allegations: Guardian
  • Representational image. Photo: Reuters
    Bangladesh reports 3 more Covid-19 cases
  • Muhammad Yunus (L) and Narendra Modi. Photo: Collected
    Modi sends Eid-ul-Adha greetings, Yunus calls for continued bilateral cooperation
  • Photo: Reuters
    Trump says Musk relationship over, warns of 'serious consequences' if he funds Democrats

Related News

  • South Africa town leader 'sad' about Trump's misuse of white crosses video
  • Trump confronts South Africa's Ramaphosa with false claims of white genocide
  • First white South Africans arrive in US as Trump claims they face discrimination
  • First white South Africans board plane for US under Trump refugee plan
  • First white South Africans to arrive under US refugee plan as soon as next week

Features

File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

11h | Features
Photo collage shows political posters in Bagerhat. Photos: Jannatul Naym Pieal

From Sheikh Dynasty to sibling rivalry: Bagerhat signals a turning tide in local politics

2d | Bangladesh
Illustration: TBS

Unbearable weight of the white coat: The mental health crisis in our medical colleges

5d | Panorama
(From left) Sadia Haque, Sylvana Quader Sinha and Tasfia Tasbin. Sketch: TBS

Meet the women driving Bangladesh’s startup revolution

5d | Panorama

More Videos from TBS

US and China to meet in London for trade talks

US and China to meet in London for trade talks

29m | TBS World
The forbidden point on Cox's Bazar beach is like a death trap

The forbidden point on Cox's Bazar beach is like a death trap

2h | TBS Today
Israeli forces seize Gaza aid boat carrying Greta Thunberg

Israeli forces seize Gaza aid boat carrying Greta Thunberg

4h | TBS World
Which way will the anti-immigration campaign in Los Angeles turn?

Which way will the anti-immigration campaign in Los Angeles turn?

5h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net